STERIS plc (STE)

Sep 24, 2026

Argus has lowered its target price for CONMED Corporation (CNMD) to $48.00, citing the medical equipment company's focus on sports medicine and general surgeries. The current stock price for CNMD is $45.18. The report, published on September 23, 2026, provides a summary of the company's business activities.

Sep 20, 2026

Corient Private Wealth LP significantly increased its stake in STERIS plc (NYSE:STE) by 109.7% in Q2, bringing its total holdings to 20,978 shares valued at $4.4 million. This move is part of broader institutional interest, with such investors owning 94.69% of the company. STERIS reported strong Q2 earnings, beating EPS estimates and seeing a 7.3% revenue increase, while also raising its quarterly dividend.

Sep 18, 2026

Shares of Steris PLC (STE) fell 1.44% to $205.04 on Friday, marking its fourth consecutive day of losses. This occurred during a mixed trading session where the S&P 500 Index rose 0.17% and the Dow Jones Industrial Average declined 0.18%. The stock's performance indicates underperformance relative to key market indices and competitors.

Sep 16, 2026

Engineers Gate Manager LP recently acquired 9,499 shares of STERIS plc (NYSE:STE) during the second quarter, valued at approximately $2 million. This purchase is part of a broader trend of institutional investors modifying their holdings in STERIS, with Goldman Sachs Group Inc. and Cerity Partners LLC also increasing their stakes. The article details STERIS's stock performance, recent earnings, analyst ratings, and a recent dividend increase.

Sep 13, 2026

National Pension Service significantly reduced its stake in STERIS plc by 83.8% in Q2, selling over 156,000 shares. Despite this, institutional investors collectively own 94.69% of the company, and analysts maintain a "Moderate Buy" rating with an average price target of $271.33. STERIS also reported strong Q2 earnings, exceeding EPS estimates, and increased its quarterly dividend.

Sep 12, 2026

Representative April McClain Delaney (D-Maryland) recently sold shares of Markel Group Inc. (NYSE:MKL) valued between $100,001 and $250,000 on August 25th, according to a September 9th filing. This sale was part of a larger divestment that included holdings in several other companies like Wabtec, Viking, and Trimble. Markel Group shares opened down 0.3% at $1,780.27, while analysts currently maintain a consensus "Hold" rating with an average price target of $2,025.